Peer-reviewedCC BY-NC-NDInternal Medicine
Mucous Membrane Pemphigoid during CPX-351 Therapy Successfully Treated with Corticosteroids
Abstract
A 58-year-old man was diagnosed with acute myeloid leukemia with myelodysplasia-related changes. Induction therapy with CPX-351 achieved complete remission, and a second course of consolidation therapy was administered. Shortly after the second course, he developed aphthous ulcers on the tongue that progressively worsened. Although a tongue biopsy showed no specific findings, serum anti-bullous pemphigoid 180 antibodies were positive. Mucous membrane pemphigoid (MMP) was diagnosed, and corticosteroid therapy led to a rapid improvement. Given the temporal relationship between CPX-351 administration and the MMP onset, CPX-351 was considered to be the likely causative agent.
Related
- A Case of Insulin Autoimmune Syndrome Complicated by IgG4-Related Disease, Both Successfully Treated with Corticosteroids
- Late-onset Acute Cellular Rejection after Lung Transplantation Triggered by a Fluctuation in the Tacrolimus Trough Level Which Was Successfully Treated with Steroid Pulse Therapy
- Severe Malnutrition Revealing Psychotic Depression in an Elderly Patient Successfully Treated With Electroconvulsive Therapy: A Case Report.
- A Case of Neurohistoplasmosis Successfully Treated With Single High-Dose Liposomal Amphotericin B
- Prolonged Primary Cytomegalovirus Infection in an Immunocompetent Adult Successfully Treated With Valganciclovir
BibTeX
@article{akimoto2026mucous,
title = {{Mucous Membrane Pemphigoid during CPX-351 Therapy Successfully Treated with Corticosteroids}},
author = {Masahiro Akimoto and Takashi Matsuki and Michiki Saito and Kengo Katsuki and Takayoshi Tachibana and Masatsugu Tanaka and Hideaki Nakajima},
journal = {Internal Medicine},
year = {2026},
month = sep,
doi = {10.2169/internalmedicine.6829-25},
url = {https://www.jstage.jst.go.jp/article/internalmedicine/65/17/65_6829-25/_article},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Mucous Membrane Pemphigoid during CPX-351 Therapy Successfully Treated with Corticosteroids
AU - Masahiro Akimoto
AU - Takashi Matsuki
AU - Michiki Saito
AU - Kengo Katsuki
AU - Takayoshi Tachibana
AU - Masatsugu Tanaka
AU - Hideaki Nakajima
PY - 2026
DA - 2026/09/01
JO - Internal Medicine
DO - 10.2169/internalmedicine.6829-25
UR - https://www.jstage.jst.go.jp/article/internalmedicine/65/17/65_6829-25/_article
AB - A 58-year-old man was diagnosed with acute myeloid leukemia with myelodysplasia-related changes. Induction therapy with CPX-351 achieved complete remission, and a second course of consolidation therapy was administered. Shortly after the second course, he developed aphthous ulcers on the tongue that progressively worsened. Although a tongue biopsy showed no specific findings, serum anti-bullous pemphigoid 180 antibodies were positive. Mucous membrane pemphigoid (MMP) was diagnosed, and corticosteroid therapy led to a rapid improvement. Given the temporal relationship between CPX-351 administration and the MMP onset, CPX-351 was considered to be the likely causative agent.
SN - 1349-7235
SN - 0918-2918
ER -